U.S. flag

An official website of the United States government

NM_000528.4(MAN2B1):c.256dup (p.Tyr86fs) AND Deficiency of alpha-mannosidase

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 14, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001947965.3

Allele description [Variation Report for NM_000528.4(MAN2B1):c.256dup (p.Tyr86fs)]

NM_000528.4(MAN2B1):c.256dup (p.Tyr86fs)

Gene:
MAN2B1:mannosidase alpha class 2B member 1 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
19p13.13
Genomic location:
Preferred name:
NM_000528.4(MAN2B1):c.256dup (p.Tyr86fs)
HGVS:
  • NC_000019.10:g.12665712dup
  • NG_008318.1:g.6069dup
  • NG_015814.1:g.3909dup
  • NM_000528.4:c.256dupMANE SELECT
  • NM_001173498.2:c.256dup
  • NP_000519.2:p.Tyr86fs
  • NP_001166969.1:p.Tyr86fs
  • NC_000019.9:g.12776522_12776523insA
  • NC_000019.9:g.12776526dup
Protein change:
Y86fs
Links:
dbSNP: rs2024217430
NCBI 1000 Genomes Browser:
rs2024217430
Molecular consequence:
  • NM_000528.4:c.256dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001173498.2:c.256dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Deficiency of alpha-mannosidase (MANSA)
Synonyms:
Lysosomal alpha-D-mannosidase deficiency; Alpha mannosidase B deficiency; Mannosidosis, alpha B lysosomal; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009561; MedGen: C0024748; Orphanet: 61; OMIM: 248500

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002195084Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 14, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of mutations in alpha-mannosidosis.

Berg T, Riise HM, Hansen GM, Malm D, Tranebjaerg L, Tollersrud OK, Nilssen O.

Am J Hum Genet. 1999 Jan;64(1):77-88.

PubMed [citation]
PMID:
9915946
PMCID:
PMC1377705

Identification of 83 novel alpha-mannosidosis-associated sequence variants: functional analysis of MAN2B1 missense mutations.

Riise Stensland HM, Klenow HB, Van Nguyen L, Hansen GM, Malm D, Nilssen Ø.

Hum Mutat. 2012 Mar;33(3):511-20. doi: 10.1002/humu.22005. Epub 2012 Jan 23. Erratum in: Hum Mutat. 2016 Aug;37(8):827. doi: 10.1002/humu.23002.

PubMed [citation]
PMID:
22161967
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV002195084.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Tyr86Leufs*6) in the MAN2B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MAN2B1 are known to be pathogenic (PMID: 9915946, 22161967). This variant has not been reported in the literature in individuals affected with MAN2B1-related conditions. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024